Unknown

Dataset Information

Development of novel isatin thiazolyl-pyrazoline hybrids as promising antimicrobials in MDR pathogens.


ABSTRACT: Microbial Multidrug Resistance (MDR) is an emerging global crisis. Derivatization of natural or synthetic scaffolds is among the most reliable strategies to search for and obtain novel antimicrobial agents for the treatment of MDR infections. Here, we successfully manipulated the synthetically flexible isatin moieties to synthesize 22 thiazolyl-pyrazolines hybrids, and assessed their potential antimicrobial activities in vitro against various MDR pathogens, using the broth microdilution calorimetric XTT reduction method. We chose 5 strains to represent the major MDR microorganisms, viz: Methicillin-resistant S. aureus (MRSA), and Vancomycin-resistant E. faecalis (VRE) as Gram-positive bacteria; Carbapenem-resistant K. pneumonia (CRKP), and Extended-spectr

SUBMITTER: Al-Warhi T 

PROVIDER: S-EPMC9629177 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature